Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

BTIG analyst Michael Gorman raised the firm’s price target on Agree Realty (ADC) to $78 from $74 and keeps a Buy rating on the shares. Agree ...

Specialty Finance Analyst Caintic holds a meeting with CEO Howard and CFO McCamey in Boston on December 4 hosted by BTIG.Don't Miss our Black ...

Oil (CL1:COM) prices and the broader energy sector have been among the worst-performing areas of the economy since the start ...

It isn’t all bad news, said John Krinsky, chief market technician at BTIG, in a Wednesday client note. Tech’s XLK -1.62% 1.5% ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 results. Read more here.

Alector (NASDAQ:ALEC – Free Report) had its target price lowered by BTIG Research from $16.00 to $5.00 in a research note ...

Fintel reports that on November 26, 2024, BTIG downgraded their outlook for Poseida Therapeutics (NasdaqGS:PSTX) from Buy to ...

Glaukos (NYSE:GKOS – Free Report) had its price target lifted by BTIG Research from $140.00 to $149.00 in a report published on Tuesday,Benzinga reports. BTIG Research currently has a buy rating on ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable ...

On Tuesday, Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $14.38 which represents a slight increase of $1.12 or 8.45% from the prior close of $13.26. The stock opened at $13.